Page last updated: 2024-09-02

quinaprilat and neostigmine bromide

quinaprilat has been researched along with neostigmine bromide in 2 studies

Compound Research Comparison

Studies
(quinaprilat)
Trials
(quinaprilat)
Recent Studies (post-2010)
(quinaprilat)
Studies
(neostigmine bromide)
Trials
(neostigmine bromide)
Recent Studies (post-2010) (neostigmine bromide)
9223443016

Protein Interaction Comparison

ProteinTaxonomyquinaprilat (IC50)neostigmine bromide (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)0.0594
AcetylcholinesteraseHomo sapiens (human)0.1112
AcetylcholinesteraseRattus norvegicus (Norway rat)0.9813
CholinesteraseEquus caballus (horse)0.07
Muscarinic acetylcholine receptorCavia porcellus (domestic guinea pig)0.045

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1

Other Studies

2 other study(ies) available for quinaprilat and neostigmine bromide

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010